C4 Therapeutics (CCCC) Depreciation and Depletion (2020 - 2026)

C4 Therapeutics' Depreciation and Depletion history runs 7 years deep, the most recent figure standing at $360000.0 for Q1 2026.

• In Q1 2026, Depreciation and Depletion fell 1.1% year-over-year to $360000.0; the TTM figure through Mar 2026 stood at $1.5 million (up 10.66% YoY), while the FY2025 annual figure was $1.5 million, up 4.62% from the prior year.
• Depreciation and Depletion was $360000.0 for Q1 2026 at C4 Therapeutics, down from $377000.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $521000.0 in Q4 2022 to a low of $128000.0 in Q4 2023.
• Historically, Depreciation and Depletion has averaged $382647.1 across 5 years, with a median of $377000.0 in 2025.
• The sharpest annual moves came in 2023 and 2024: Depreciation and Depletion plunged 75.43% in 2023, then surged 184.38% in 2024.
• A 5-year view of Depreciation and Depletion shows it stood at $521000.0 in 2022, then slumped by 75.43% to $128000.0 in 2023, then soared by 184.38% to $364000.0 in 2024, then increased by 3.57% to $377000.0 in 2025, then slipped by 4.51% to $360000.0 in 2026.
• The last three Depreciation and Depletion figures came in at $360000.0 (Q1 2026), $377000.0 (Q4 2025), and $384000.0 (Q3 2025), per Business Quant data.